Many Americans battling diabetes are turning to a new class of injected drugs that includes blockbusters like Ozempic (semaglutide) and Mounjaro (tirzepatide). But a new study finds half of patients who use these “second line” therapies – a class called GLP-1 RAs – quit them… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, […]
LOS ANGELES — Los Angeles County public schools are rolling out an ambitious effort to offer free mental health services to their 1.3 million K-12 students, a key test of California Gov. Gavin Newsom’s sweeping, $4.7 billion program to address a youth mental health crisis. Spearheaded by the county’s Medi-Cal plans — which provide health […]
For the third consecutive year, psychologists across the country say that they are seeing more patients with worsening symptoms, many of whom are needing more treatment time. However, most psychologists have no openings for new patients, and many who keep waiting lists say… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]
© 2024 BETTER/SMARTER.ME, A division of the Institute for the Future of Human Potential
200 First St. SW Rochester, MN 55905 | 1-800-328-IFHP
IFHRP research has not been evaluated by the Food and Drug Administration or any government agency.
IFHRP research is not intended to diagnose, treat, cure, or prevent disease.